norethindrone acetate has been researched along with Arthritis, Rheumatoid in 1 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pullerits, R | 1 |
| d'Elia, HF | 1 |
| Tarkowski, A | 1 |
| Carlsten, H | 1 |
1 trial available for norethindrone acetate and Arthritis, Rheumatoid
| Article | Year |
|---|---|
The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
Topics: Alkaline Phosphatase; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Bone Density; Bone Resorpti | 2009 |